  |
Ultrafine
Appoint Dr Rick Dyer as Head of Chemical Operations |
Ultrafine,
the chemistry service provider based in Manchester, UK have appointed
Dr
Rick Dyer as Head of Chemical Operations.
Dr Dyer has gained extensive experience of process research,
development and GMP synthesis in his career with Glaxo, Chiroscience and
Roche UK.
Dr
Mike Harris now becomes Head of Business Development.
These
appointments allow Ultrafine, an established player with 61 employees in
the field of contract research services, to continue its rapid expansion
working within the global marketplace.
-
copy ends -
About
Ultrafine
Ultrafine
provides a contract research service, delivering high quality chemistry
support to Biotechnology and Pharmaceutical companies.
They complement the existing resources of companies who already
have in-house chemistry, but can also provide project management services
and chemistry functions to companies who do not have their own chemistry
resources.
Ultrafine’s
services offersynthetic and analytical chemistry from lead development and
optimisationthrough scale-up to the supply of clinical trial materials to
cGMP.
Company
Contact
Dr
Mike Harris, Ultrafine (UFC Ltd), Synergy House, Guildhall Close,
Manchester Science Park, M15 6SY Tel 0161 2325500, Fax 0161 2325501
Email
info@ultrafine.co.uk
web www.ultrafine.co.uk
Editor
Contact:
Dr.
Nicola Reed-Jones, Northbank Communications, Meadowside, Mountbatten Way,
Congleton, CW12 1DN, UK Tel
01260 296500, Fax 01260 296501
email
n.reedjones@northbankcommunications.com
web www.northbankcommunications.com
